Real-time enrollment status for this clinical high risk for psychosis (chr) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:54 AM UTC
| NCT Number | NCT05968560 |
| Recruiting Status | Recruiting |
| Condition | Clinical High Risk for Psychosis (CHR) |
| Phase | Clinical Trial |
| Target Enrollment | 72 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of July 13, 2026: Clinical trial NCT05968560 is currently recruiting participants. This clinical trial study for clinical high risk for psychosis (chr) is actively seeking new participants at 1 location across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05968560 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05968560 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.